Additional file 3. Characterization of the bioluminescent Ca2+ indicators in HeLa. (a) A series of pseudo-coloured ratio images of HeLa cells expressing GmNL(Ca2+), following 10 μM histamine stimulation (arrow). Scale bar, 10 μm. (b) Time course of the B/B0 ratio change at an ROI (white box in (a)). Number indicates the time point of each image in (a)
mMSC distribution between day 14 and 30. (a) From day 24 onwards for IC-injected mice, it was necess...
Figure S3. Phenotypic characterization of hiPSC-CMs. hiPSC-CMs were characterized using specific cel...
The emerging heart-on-a-chip platforms are promising approaches to establish cardiac cell/tissue mod...
OBJECTIVE: Cardiomyocytes derived from human-induced pluripotent stem cells are a powerful platform ...
Additional file 4. Evaluation of mean beat interval before and after treatment with either 10 μM Dop...
Showing cell tracking by bioluminescence in immunosuppressed CD1 mice. (a) Representative images of ...
Figure S2. Beating cardiomyocyte cell cluster showing particles distributed across its mass. Demonst...
The advent of the human-induced pluripotent stem cell (hiPSC) technology has transformed biomedical ...
We present an integrated platform comprised of a biomimetic substrate and physiologically aligned hu...
<p>(A) Bioluminescence images of an individual cell with luciferase driven by <i>Hes1</i> promoter. ...
Figure S3. Ca2+ signal measurement in E2-treated GCaMP2-MCF-7 cells. Cells were cultured in E2-free ...
In this work, we describe a novel fluorescence indicator system for the in-vitro characterization of...
Introduction: Proper characterization of cardiac tissues is a complex problem, as in addition to the...
Figure S3. Video of beating CMC colonies. Morphology and ability of cardiomyocytes to beat following...
High-Content Screening (HCS) is a form of high throughput screening (HTS) that couples automated mic...
mMSC distribution between day 14 and 30. (a) From day 24 onwards for IC-injected mice, it was necess...
Figure S3. Phenotypic characterization of hiPSC-CMs. hiPSC-CMs were characterized using specific cel...
The emerging heart-on-a-chip platforms are promising approaches to establish cardiac cell/tissue mod...
OBJECTIVE: Cardiomyocytes derived from human-induced pluripotent stem cells are a powerful platform ...
Additional file 4. Evaluation of mean beat interval before and after treatment with either 10 μM Dop...
Showing cell tracking by bioluminescence in immunosuppressed CD1 mice. (a) Representative images of ...
Figure S2. Beating cardiomyocyte cell cluster showing particles distributed across its mass. Demonst...
The advent of the human-induced pluripotent stem cell (hiPSC) technology has transformed biomedical ...
We present an integrated platform comprised of a biomimetic substrate and physiologically aligned hu...
<p>(A) Bioluminescence images of an individual cell with luciferase driven by <i>Hes1</i> promoter. ...
Figure S3. Ca2+ signal measurement in E2-treated GCaMP2-MCF-7 cells. Cells were cultured in E2-free ...
In this work, we describe a novel fluorescence indicator system for the in-vitro characterization of...
Introduction: Proper characterization of cardiac tissues is a complex problem, as in addition to the...
Figure S3. Video of beating CMC colonies. Morphology and ability of cardiomyocytes to beat following...
High-Content Screening (HCS) is a form of high throughput screening (HTS) that couples automated mic...
mMSC distribution between day 14 and 30. (a) From day 24 onwards for IC-injected mice, it was necess...
Figure S3. Phenotypic characterization of hiPSC-CMs. hiPSC-CMs were characterized using specific cel...
The emerging heart-on-a-chip platforms are promising approaches to establish cardiac cell/tissue mod...